The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Drug-Related Hepatotoxicity
Abstract
Given its rarity, drug-related hepatotoxicity may not be seen during the initial clinical trials of a new medication. After approval, when many more patients are exposed, toxic effects that are very infrequent may emerge. This review explains the difficulties in identifying the cause of hepatotoxic effects in such situations and provides clinical guidance with regard to the detection, evaluation, and possible prevention of drug-related hepatotoxicity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
DILI is a common adverse drug reaction that can lead to liver failure and even death.
“Drug-induced liver injury (DILI) is a common adverse drug reaction (ADR), and it can lead to liver failure and even death.[1][2][3]”
From Incidence and Etiology of Drug-Induced Liver Injury in Mainland China (2019) · cites this paper as [2]
Citations
Cites
Lee, W. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021844 · Cited by 1,594
Hepatotoxic Effects of Tacrine Administration in Patients With Alzheimer's Disease
Watkins, P. B. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510370044030 · Cited by 829
Flagged first, then by citations
Research works printed but not linked: 56
- 10.1055/s-2002-30101 · DOI
- 10.1053/jhep.2002.34857 · DOI
- 10.1002/hep.20703 · DOI
- Bohan TP, 2001, Neurology, 41, 1405, 10.1212/WNL.56.10.1405 · DOI
- 10.1016/0168-8278(90)90124-A · DOI · Paper page
- Rosalski SB, McIntyre N. Biochemical investigations in the management of liver disease. In: Bircher J, Benhamou J-P, McIntyre N, Rizetto M, Rodes J, eds. Oxford handbook of clinical hepatology. 2nd ed. Oxford, England: Oxford University Press, 1999:504.
- 10.1002/hep.20800 · DOI · Paper page
- 10.1053/j.gastro.2005.05.006 · DOI
- 10.1001/jama.281.11.1014 · DOI
- 10.1001/jama.271.13.992 · DOI
- 10.1086/381446 · DOI
- 10.1016/S0140-6736(00)03137-8 · DOI
- 10.1073/pnas.84.2.551 · DOI
- 10.1016/S0168-8278(97)82329-X · DOI
- 10.1038/clpt.1992.135 · DOI
- Yun CH, 1993, Drug Metab Dispos, 21, 403
- 10.1056/NEJM199810223391707 · DOI
- 10.1016/S1471-4914(01)02026-3 · DOI
- 10.1055/s-2001-12929 · DOI
- 10.1055/s-2002-30100 · DOI
- Zimmerman HJ. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 1999.
- 10.1146/annurev.pa.23.040183.000511 · DOI
- 10.1001/jama.272.23.1845 · DOI
- 10.1053/j.gastro.2004.03.030 · DOI
- 10.1016/S0168-8278(97)80492-8 · DOI
- 10.1056/NEJMra020526 · DOI
- 10.1053/jhep.2002.32102 · DOI
- 10.1124/mol.104.007146 · DOI
- 10.3816/CCC.2005.n.018 · DOI
- 10.1056/NEJM199908193410802 · DOI
- 10.1023/A:1005661516165 · DOI
- 10.1056/NEJMra011775 · DOI · Paper page
- 10.1053/gast.2003.50032 · DOI
- 10.1053/j.gastro.2004.02.015 · DOI · Paper page
- 10.1053/jhep.2001.21083 · DOI
- 10.1016/0895-4356(93)90101-6 · DOI · Paper page
- 10.1016/0895-4356(93)90102-7 · DOI · Paper page
- 10.1517/14740338.3.4.329 · DOI
- 10.1002/hep.510260319 · DOI · Paper page
- 10.1053/jhep.2001.20645 · DOI · Paper page
- 10.1080/01926230590522356 · DOI
- 10.1016/S0168-8278(97)82330-6 · DOI
- 10.1002/hep.1840150212 · DOI
- 10.1016/S0002-9149(02)02355-X · DOI
- The binomial distribution. In: Rosner B. Fundamentals of biostatistics. Belmont, Calif.: Duxbury Press, 1995:82-5.
- 10.1056/NEJM199803263381314 · DOI
- 10.1016/S0002-9343(02)01529-2 · DOI
- 10.1002/hep.20598 · DOI · Paper page
- 10.1001/jama.269.21.2765 · DOI
- 10.1016/0140-6736(93)90895-N · DOI
- Vandenbroucke JP, 2001, Ann Intern Med, 134, 330, 10.7326/0003-4819-134-4-200102200-00017 · DOI
- 10.1007/s002280100265 · DOI
- 10.1056/NEJMp038145 · DOI
- 10.1056/NEJMra020021 · DOI
- 10.1002/hep.20948 · DOI
- Hoofnagle JH, 2004, Hepatology, 40, 773, 10.1002/hep.20445 · DOI
Cited by
Sorted by citations
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
The safety of statins in clinical practice
Armitage, J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60716-8 · Cited by 833
Drug-Induced Acute Liver Failure: Results of a U.S. Multicenter, Prospective Study
Reuben, A., Koch, D. G., & Lee, W. M. (2010) · Hepatology · doi:10.1002/hep.23937 · Cited by 772
Drug-induced liver injury—types and phenotypes
Hoofnagle, J. H., & Björnsson, E. S. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1816149 · Cited by 652
Incidence and Etiology of Drug-Induced Liver Injury in Mainland China
Shen, T., Liu, Y., Shang, J., Xie, Q., Li, J., Yan, M., Xu, J., Niu, J., Liu, J., Watkins, P. B., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.02.002 · Cited by 615
Tan, C. Y., Lai, R. C., Wong, W., Dan, Y. Y., Lim, S.-K., & Ho, H. K. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt465 · Cited by 548
Drug-Induced Liver Injury Network (DILIN) Prospective Study: Rationale, Design and Conduct
Fontana, R. J., Watkins, P. B., Bonkovsky, H. L., Chalasani, N., Davern, T., Serrano, J., & Rochon, J. (2009) · Drug Safety · doi:10.2165/00002018-200932010-00005 · Cited by 486
Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines
Devarbhavi, H., Aithal, G., Treeprasertsuk, S., Takikawa, H., Mao, Y., Shasthry, S. M., Hamid, S., Tan, S. S., Philips, C. A., George, J., et al. (2021) · Hepatology International · doi:10.1007/s12072-021-10144-3 · Cited by 181
Drug-induced liver injury: a clinical update
Ghabril, M., Chalasani, N., & Björnsson, E. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283383c7c · Cited by 123
Rosenstock, J., Bergenstal, R. M., Blevins, T. C., Morrow, L. A., Prince, M. J., Qu, Y., Sinha, V. P., Howey, D. C., & Jacober, S. J. (2013) · Diabetes Care · doi:10.2337/dc12-0067 · Cited by 96
The Nuremberg Code subverts human health and safety by requiring animal modeling
Greek, R., Pippus, A., & Hansen, L. A. (2012) · BMC Medical Ethics · doi:10.1186/1472-6939-13-16 · Cited by 78
Hepatic Events Associated with Atomoxetine Treatment for??Attention-Deficit??Hyperactivity Disorder
Bangs, M. E., Jin, L., Zhang, S., Desaiah, D., Allen, A. J., Read, H. A., Regev, A., & Wernicke, J. F. (2008) · Drug Safety · doi:10.2165/00002018-200831040-00008 · Cited by 68
Acute and fulminant hepatitis induced by flutamide: Case series report and review of the literature
Javier, B., Magdalena, B., Roberto, S., Ricardo, L., Rodrigo, Z., Jaime, P., Erwin, B., & Luis, C. (2011) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31595-9 · Cited by 62
Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update
Mao, Y., Ma, S., Liu, C., Liu, X., Su, M., Li, D., Li, Y., Chen, G., Chen, J., Chen, J., et al. (2024) · Hepatology International · doi:10.1007/s12072-023-10633-7 · Cited by 62
Rathi, C., Pipaliya, N., Patel, R., Ingle, M., Phadke, A., & Sawant, P. (2017) · Annals of Hepatology · doi:10.5604/01.3001.0009.8600 · Cited by 61
Reddy, M., Fenn, S., Rolnik, D. L., Mol, B. W., da Silva Costa, F., Wallace, E. M., & Palmer, K. R. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.08.019 · Cited by 61
Montastruc, F., Scotto, S., Vaz, I. R., Guerra, L. N., Escudero, A., Sáinz, M., Falomir, T., Bagheri, H., Herdeiro, M. T., Venegoni, M., et al. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000094 · Cited by 33
Lethal complications after poisoning with chloroform — case report and literature review
Lionte, C. (2010) · Human & Experimental Toxicology · doi:10.1177/0960327109357142 · Cited by 27
Complex Gene−Chemical Interactions: Hepatic Uroporphyria As a Paradigm
Smith, A. G., & Elder, G. H. (2010) · Chemical Research in Toxicology · doi:10.1021/tx900298k · Cited by 20
Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury
Das, S., Behera, S. K., Xavier, A. S., Velupula, S., Dkhar, S. A., & Selvarajan, S. (2018) · Clinical Drug Investigation · doi:10.1007/s40261-017-0601-5 · Cited by 19
Answers to the Most Common Questions About the Hepatic Safety Profile of Duloxetine
Wohlreich, M. M., Acharya, N., Strombom, I., Kuritzky, L., Robinson, M., Heinloth, A. N., Regev, A., & Wernicke, J. F. (2008) · Postgraduate Medicine · doi:10.3810/pgm.2008.07.1803 · Cited by 12
Metadata
- Authors
- Navarro, V. J., & Senior, J. R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-02-16
- Volume
- 354
- Issue
- 7
- Pages
- 731-739
- ISSN
- 0028-4793
- 1533-4406
- Cited by
- 811
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review